PetMed Express, Inc.
PETS · NASDAQ
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.73 | 0.05 | -0.84 | -0.89 |
| FCF Yield | -0.46% | -0.20% | 6.85% | 3.22% |
| EV / EBITDA | 4.86 | -37.62 | 20.58 | 15.15 |
| Quality | ||||
| ROIC | -18.92% | -9.85% | 3.80% | 13.13% |
| Gross Margin | 30.46% | 27.98% | 27.65% | 28.14% |
| Cash Conversion Ratio | -0.75 | -0.58 | 119.33 | 0.88 |
| Growth | ||||
| Revenue 3-Year CAGR | -4.04% | 0.92% | -5.42% | -1.27% |
| Free Cash Flow Growth | -103.61% | -100.86% | 34.62% | -55.51% |
| Safety | ||||
| Net Debt / EBITDA | -8.01 | 48.68 | -9.38 | -4.11 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 72.51 |
| Efficiency | ||||
| Inventory Turnover | 9.74 | 7.09 | 9.77 | 6.02 |
| Cash Conversion Cycle | -13.29 | -11.01 | -9.67 | 11.81 |